Rudra Bioventures Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 93.76%
- Profit Growth 51.59%
- Ebitda 150.84%
- Net Worth 59.03%
- Total Assets 90.01%
About Rudra Bioventures
Rudra Bioventures Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2006 and has a history of 19 years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikrant Bhatt and Jayashree Bhatt serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U31225KA2006PTC038389
-
Company No.
038389
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Rudra Bioventures Private Limited offer?
Rudra Bioventures Private Limited offers a wide range of products and services, including Industrial Acid, Fatty Acid, Dietary Supplements, General Vitamin Premix Powder, Probiotic And Prebiotic Drugs, Probiotic Plus Powder, Gastrointestinal Drugs, Lactobacillus Acidophilus Powder, Fish Foods, Aqua Probiotics.
Who are the key members and board of directors at Rudra Bioventures?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikrant Bhatt
|
Director | 06-Feb-2006 | Current |
|
Jayashree Bhatt
|
Director | 06-Feb-2006 | Current |
Financial Performance of Rudra Bioventures.
Rudra Bioventures Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 93.76% increase. The company also saw a substantial improvement in profitability, with a 51.59% increase in profit. The company's net worth Soared by an impressive increase of 59.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rudra Bioventures?
In 2017, Rudra Bioventures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rudra Bioventures?
Unlock and access historical data on people associated with Rudra Bioventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rudra Bioventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rudra Bioventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.